Search clinical trials for: Arbovirus Infections

Total 56409 results

Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Purified Inactivated Japanese Encephalitis Vaccine

Japanese Encephalitis Virus Disease

China
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID)

No longer available

Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure

West Nile Virus Infection
Takeda

Completed

Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants

Flavivirus Infections | Healthy Participants | Virus, Zika | Zika Virus Disease

United States, Puerto Rico
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Treatment of West Nile Virus With MGAWN1 (PARADIGM)

Encephalitis | Meningitis | West Nile Virus Infection | West Nile Fever | West Nile Neuroinvasive Disease | Acute Flaccid Paralysis
Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Tick Borne Encephalitis

Austria
Agence Sanitaire et Sociale de Nouvelle Calédonie
Institut Pasteur; World Health Organization; Pacific Community; Institut de la...

Suspended

Baromètre Santé Adulte 2021-2022

Diabetes | Renal Failure | Chronic Disease | Hypercholesterolemia | Malaria | SARS-CoV Infection | Dengue Fever | Chikungunya | Zika | Ross River

New Caledonia
Epicentre
Kenya Medical Research Institute

Completed

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) (YEFE)

Yellow Fever

Uganda, Kenya
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

GLS-5700 in Dengue Virus Seropositive Adults

Healthy | Zika

Puerto Rico
Westat
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Completed

Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP)

HIV | Pregnant Women | Zika Virus

United States, Puerto Rico, Brazil
Themis Bioscience GmbH

Completed

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (MV-ZIKA-RSP)

Zika Virus Infection

Austria
Themis Bioscience GmbH

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

Chikungunya Virus Infection

Austria, Germany
University of Maryland, Baltimore
United States Army Medical Materiel Development Activity; Medical Technology...

Completed

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

Dengue

United States
Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Malaria | Malaria Vaccines

Ghana
Etablissement Français du Sang, Martinique
Institut National de la Santé Et de la Recherche Médicale, France; Sanofi Pasteur... and other collaborators

Completed

Dengue Seroprevalence Study in Blood Donors in the French West Indies (DengSeroprevAn)

Dengue | Blood Donors

Guadeloupe, Martinique
RTI International
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Zika in Infants and Pregnancy (ZIP)

Zika Virus Disease (Disorder)

Colombia, Brazil, Guatemala, Nicaragua, Peru, Puerto Rico
GlaxoSmithKline
Novartis Vaccines

Completed

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Virus Diseases | Tick Borne Encephalitis

Czechia
Centre Hospitalier de Cayenne
Centre Hospitalier de Kourou; Centre Hospitalier de l'Ouest Guyanais; Centres... and other collaborators

Completed

Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana (CMFdeng)

Fever | Dengue | Pregnancy Preterm | Infant, Newborn | Women | Parturition; Precipitate

French Guiana
Centre Hospitalier Universitaire Saint Pierre

Active, not recruiting

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

HIV Infections | Yellow Fever Vaccine

Belgium
Valneva Austria GmbH

Completed

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Encephalitis

Philippines
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Chikungunya

Puerto Rico
ModernaTX, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults

Prevention of Chikungunya Virus Infection

United States
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Dengue Fever

United States
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

COVID-19 | Yellow Fever

Brazil
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
U.S. Army Medical Research and Development Command

Active, not recruiting

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

Dengue Virus

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

Alphavirus Infections | Eastern Equine Encephalitis | Venezuelan Equine Encephalitis | Western Equine Encephalitis

United States
University of Notre Dame
University of California, Davis

Completed

Spatial Repellents for Arbovirus Control

Arbovirus Infections

Peru
Institute of Tropical Medicine, Belgium

Withdrawn

RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection (CHIK_urine)

Chikungunya Fever

Belgium, Aruba
Institute of Tropical Medicine, Belgium

Completed

Filter Paper Blood Spots Collected During Fever as a Source for Post-travel Diagnosis in Travelers (JOKA-II)

Fever

Belgium
Oswaldo Cruz Foundation
National Institute of Allergy and Infectious Diseases (NIAID); Wellcome Trust; Walter Reed Army Institute of Research (WRAIR) and other collaborators

Completed

Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil (ZikaBra)

Zika Virus

Brazil
Institute of Tropical Medicine, Belgium

Completed

Persistence of Zika Virus in Semen After Acute Infection

Transmission | Zika Virus | Zika Virus Disease | Virus Shedding

Belgium
Mahidol University

Completed

Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients (PKIDEN)

Dengue Hemorrhagic Fever

Thailand
SRI International
US Army Medical Research Institute of Infectious Diseases

Unknown

Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (VEEV)

Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | RNA Virus Infections | Virus Diseases | Encephalitis | Encephalitis, Viral | Central Nervous System Viral Diseases | Central Nervous System Infections | Infectious Encephalitis | Encephalomyelitis | Alphavirus Infections | Togaviridae... and other conditions

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

Dengue

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (VEE)

Venezuelan Equine Encephalomyelitis Virus Disease

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine (VEE TC-83)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Unknown

Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

Western Equine Encephalitis

United States
Institute of Tropical Medicine, Belgium
Universiteit Antwerpen; Victor Babes Hospital, Bucharest, Romania

Withdrawn

Prospective Investigation of Oxidative Stress in West Nile Virus Infection (PROWENI)

Oxidative Stress | West Nile Virus | West Nile Fever | West Nile Fever Encephalitis | West Nile Fever Meningitis | West Nile Meningitis | West Nile Virus Meningoencephalitis | West Nile Fever Meningoencephalitis | West Nile Fever With Neurologic Manifestation

Romania
Sormland County Council, Sweden
Karolinska Institutet; Helsingfors university

Completed

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Sweden, Finland
Pfizer

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Tick-borne Encephalitis (TBE)

Poland
Windward Islands Research and Education Foundation
National Institutes of Health (NIH); Stanford University; St. George's University

Completed

Zika and Neurodevelopment Among Infants in Grenada

Neurocognitive Deficit | Zika Virus Infection | Development, Child | Neurodevelopmental Abnormality

Grenada
Mexican Emerging Infectious Diseases Clinical Research...
National Institute of Allergy and Infectious Diseases (NIAID); Secretaria de...

Completed

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico (Zik01)

Dengue | Chikungunya | Zika Virus Disease (Disorder)

Mexico
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Measles Vectored Chikungungya Vaccine

Chikungunya Virus Infection

United States
University Hospital, Toulouse
Institut Pasteur; Centre Hospitalier Universitaire de Pointe-a-Pitre

Completed

Pilot Study to Detect Zika Virus in Sperm (ZIKSPERM)

Viruses

Guadeloupe
University of Stirling
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique... and other collaborators

Unknown

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC (MobEboDRC)

Malaria | Yellow Fever | Ebola Virus Disease | Typhoid Fever | Dengue Fever | Chikungunya Fever

Canada, Congo, The Democratic Republic of the, Germany, Senegal
Bharat Biotech International Limited

Completed

Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Chikungunya

India
National Institute of Allergy and Infectious Diseases...

Completed

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Chikungunya Virus Infection

Dominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique

Search clinical trials for: Arbovirus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations